Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2017 | 2 |
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer.
Clin Epigenetics. 2023 Dec 13;15(1):193. doi: 10.1186/s13148-023-01605-7.
Clin Epigenetics. 2023.
PMID: 38093305
Free PMC article.
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis.
Mendaza S, Guerrero-Setas D, Monreal-Santesteban I, Ulazia-Garmendia A, Cordoba Iturriagagoitia A, De la Cruz S, Martín-Sánchez E.
Mendaza S, et al. Among authors: monreal santesteban i.
Biomedicines. 2021 Oct 4;9(10):1394. doi: 10.3390/biomedicines9101394.
Biomedicines. 2021.
PMID: 34680511
Free PMC article.
Item in Clipboard
ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Azúa YR, Aguiar B, Beloqui R, Armendáriz P, Arriola M, Martín-Sánchez E, Guerrero-Setas D.
Mendaza S, et al. Among authors: monreal santesteban i.
Int J Mol Sci. 2020 Jan 30;21(3):903. doi: 10.3390/ijms21030903.
Int J Mol Sci. 2020.
PMID: 32019179
Free PMC article.
Item in Clipboard
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Blanco-Luquin I, Córdoba A, Vicente-García F, Pérez-Janices N, Escors D, Megías D, López-Serra P, Esteller M, Illarramendi JJ, Guerrero-Setas D.
Martín-Sánchez E, et al. Among authors: monreal santesteban i.
Oncotarget. 2017 Feb 28;8(9):15789-15801. doi: 10.18632/oncotarget.15004.
Oncotarget. 2017.
PMID: 28178655
Free PMC article.
Item in Clipboard
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Vicente-García F, Blanco-Luquin I, De La Cruz S, Aramendia A, Guerrero-Setas D.
Martín-Sánchez E, et al. Among authors: monreal santesteban i.
Clin Epigenetics. 2017 Jan 24;9:7. doi: 10.1186/s13148-016-0309-z. eCollection 2017.
Clin Epigenetics. 2017.
PMID: 28149335
Free PMC article.
Item in Clipboard
Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.
Blanco-Luquin I, Guarch R, Ojer A, Pérez-Janices N, Martín-Sánchez E, Maria-Ruiz S, Monreal-Santesteban I, Blanco-Fernandez L, Pernaut-Leza E, Escors D, Guerrero-Setas D.
Blanco-Luquin I, et al. Among authors: monreal santesteban i.
Pathol Int. 2015 Sep;65(9):476-85. doi: 10.1111/pin.12332. Epub 2015 Jul 27.
Pathol Int. 2015.
PMID: 26222671
Item in Clipboard
Cite
Cite